[FDA] Designation given to drugs that offer major advances in treatment, or provide a treatment where no adequate therapy exists, where the time it takes FDA to review a new drug application is reduced,.
Glossary
Priority Review
Resources
Take advantage of the knowledge and best practices gained from more than 20 years of research, innovation and development for the health and life sciences sectors.
Glossary
The Life Sciences glossary with terminology, acronyms, for regulatory, quality, compliance, clinical trials, and pharmacovigilance software.
Found 371 Results
Page 1 of 2
Page 1 of 2
Page 1 of 2
Page 1 of 2